Inspect an author's raw data, methods, and reproducibility across their publications.
Press Enter β΅ to find
Explore by Goal
"Just like a single cell, the character of our lives is determined not by our genes but by our responses to the environmental signals that propel life."
- Bruce H. Lipton
Quick Explanation
Copied
Matthew J. Bertin β evidence-based scientific profile (from provided works only)
Strength: Demonstrates a recurring expertise pattern in natural products / cyanobacterial chemistry plus mass spectrometry + computational workflows, including genome mining, molecular networking, and pattern-finding for downstream annotation (
Scientific caution: Several contributions (based on the provided 2026 raw-data records) rely on genome/cheminformatics-driven inference that is explicitly limited by the depth of biochemical reconstitution performed for every step (
Long Explanation
Author Review: Matthew J. Bertin (evidence-based, skeptical)
Scope note: this review uses ONLY the information explicitly provided in your prompt (OpenAlex snippets + the three 2026 raw-data records + the listed top works). No missing works are assumed.
VISUALS FIRST β key numeric signals extracted from the provided 2026 records
EXPLAIN SECOND β what these numbers imply (and what they do NOT)
1) Natural-product / cyanobacterial chemistry anchoring. The 2026 Floridanema-focused record reports new floridanemamide structures with explicit stereochemical corroboration steps (Marfeyβs amino-acid stereochemistry; Ξ±-keto acid starter initiation concepts; and structural confirmation via HRESIMS/NMR and derivatization) while simultaneously stating that the broader initiation framework needs further experimental biochemical verification ().
2) MS/MS workflow generalization with explicit limitations. The 2026 cyanoHAB monitoring record claims a generalizable MS/MS annotation workflow using GNPS2 MassQL and network-based product-ion searches, and it includes concrete constraints: fragmentation/adduct biases and inability to resolve isomers with product-ion approaches; limited quantitation; and limited temporal sampling ().
3) Interdisciplinary breadth (including topical permeability studies). The provided 2022 CBD permeability record is in vitro and explicitly uses artificial membrane systems (PAMPA and Franz cell) and includes sponsor/contract funding notes; it also includes a clear inference boundary (in vitro permeability β in vivo skin permeation) ().
Scientific strength (from provided evidence)
Core strengths
Evidence-aware method development: The 2026 cyanoHAB record emphasizes workflow generalization (GNPS2 MassQL + networking) while explicitly enumerating technical failure modes (isomer resolution and quantitation limitations, network overrepresentation biases) ().
Structural chemistry + stereochemical confirmation emphasis: The Floridanema record includes explicit stereochemical determination (Marfeyβs analysis) and multiple corroborating analytical modalities (HRESIMS, 1D/2D NMR) rather than relying on MS-only inference ().
Mass spectrometry computational direction: The 2025 βuniversal languageβ MS pattern paper (coauthor listing) targets reanalysis/pattern discovery for raw untargeted MS datasets, aligning with the MS/MS workflow themes seen in the 2026 records ().
Genome-guided inference vs. biochemical proof: The Floridanema record explicitly limits its initiation-programming framework by noting incomplete biochemical validation for all steps and the need for experimental verification of proposed mechanisms ().
MS-based annotation constraints: The cyanoHAB recordβs own stated boundaries (isomer resolution, lack of absolute quantitation, and bias from fragmentation/adduct formation) mean that downstream ecological/toxicological conclusions require additional orthogonal testing ().
Sampling design and generality: The cyanoHAB recordβs limited temporal sampling window is a known vector for missing time-dependent toxin/metabolite dynamics; the record also indicates sample source constraints (e.g., fraction library composition) and reliance on standard library coverage ().
In vitro permeability β in vivo transport: The 2022 CBD record uses artificial membranes and explicitly frames the need for in vivo confirmation; it also lists funding/COI elements connected to industry, which warrants careful neutrality checks when interpreting βdermatological applicationβ implications ().
How strong is the scientific epistemology here?
Known vs inferred: The provided records show strong grounding in analytical confirmation (HRESIMS, NMR, stereochemical analyses; reported HRMS errors and explicit NMR deposit identifiers) while simultaneously marking portions that are mechanistically inferred from genome architecture or MS network logic ().
Counterfactual falsification plans: The Floridanema record explicitly proposes what would falsify initiation claims (e.g., biochemical reconstitution showing Ξ±-keto acid starters are not required) and similar falsification framing appears in the cyanoHAB record for annotation/workflow claims ().
Evidence-based links to author-associated higher-impact works (from your prompt)
MS computational patterning direction: Nature Methods 2025 coauthored βuniversal language for finding mass spectrometry data patternsβ ().
Forward-looking: what would most improve confidence in the authorβs mechanistic claims?
More orthogonal biochemical reconstitution for the initiation-programming logic in the Floridanema record (explicitly flagged as incomplete validation) ().
More quantitative validation (beyond product-ion/class-level annotation) to convert MS-network presence into absolute abundance where it matters for ecology/toxicology decisions (explicitly constrained in the cyanoHAB record) ().
Run an iterative βAI Scientistβ agent to deepen the critique
This will re-check internal consistency, extract additional quantitative constraints from the provided records, and produce a more structured falsification map.
Feedback:
Updated: July 07, 2026
BGPT Author Review
Scientific Quality
70%
Strength appears credible but bounded by evidence access: from the provided records, Bertin shows solid analytical/verifiable work (HRESIMS/NMR/stereochemistry in the Floridanema study; MS/MS workflow claims with explicit technical limits in the cyanoHAB monitoring study). The main rigor risk is that some mechanistic conclusions are genome-inferred and explicitly not fully biochemically validated; similarly, MS-network class annotation has known constraints (isomer ambiguity, adduct/fragmentation biases, no absolute quant). Communication breadth appears wide (natural products β MS computational methods β permeability in vitro), which can be a strength for interdisciplinary synthesis but can dilute domain-specific depth unless tightly validated. Citation metrics from OpenAlex are suggestive but not fully auditably mapped here to study-level rigor beyond the provided snippets.
Communication Quality
60%
Based on the promptβs extracted record summaries/limitations, the work communicates boundaries and limitations fairly directly (e.g., explicit MS annotation constraints; need for biochemical verification; in vitro vs in vivo caveat). However, the provided information is not enough to judge clarity of the authorβs own writing style across all publications; also, cross-domain outputs (metabolomics/genomics + CBD permeability) can lead to variable audience alignment.
Author Novelty
80%
The 2026 records emphasize generalizable workflows (MassQL/GNPS2 class annotation) and repeated βstarter-unit logicβ framing in cyanobacterial biosynthesis, suggesting non-trivial methodological and conceptual novelty. The 2025 MS βuniversal languageβ direction further supports novelty in computational MS reusability/patterning. That said, without full-text review for all claims, novelty is inferred from the promptβs described purposes and reported contributions rather than independently verified line-by-line.
Scientific Rigor
70%
Rigor looks moderate-to-strong for analytical confirmation (explicit stereochemistry + NMR + HRESIMS in the Floridanema record; HRMS error and NMR references in the cyanopeptide record). Rigor is more limited when moving from chemistry/annotation to mechanistic causality or quantitative toxicity, where the prompt explicitly notes gaps (biochemical validation not comprehensive; MS annotation cannot resolve isomers or provide absolute quantitation; toxicity requires further targeted assays/in vivo). Overall: rigorous measurement, cautious inference.
It extracts numeric key fields (m/z, HRMS ppm, IC50, diffusion concentrations) from the provided records, builds publication-grade plots, and outputs a falsification-focused evidence table.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The genome-inferred initiation mechanisms are universally sufficient for Athmu/Atpoa formation without needing biochemical validation; this is unlikely given the promptβs explicit limitation that initiation frameworks require experimental biochemical verification.
MS/MS product-ion networking can uniquely and absolutely quantify cyanopeptide isomers in complex bloom matrices; this is unlikely because the prompt explicitly states isomer resolution and absolute quantitation are not provided by product-ion approaches.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion